UnitedHealth shares slid below Warren Buffett's entry price as the company forecasts its first revenue decline in 30 years. Amid Medicare pressures, 2026 revenue is expected to drop 2%. However, Bernstein highlights the company's expanding AI strategy as a potential long-term advantage for the embattled insurer.